Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Thermo Fisher Buys Prionics

by Ann M. Thayer
March 24, 2014 | A version of this story appeared in Volume 92, Issue 12

[+]Enlarge
Credit: Shutterstock
Prionics has diagnostic tools for bovine spongiform encephalopathy, which afflicts cows and other animals.
A cow of some kind.
Credit: Shutterstock
Prionics has diagnostic tools for bovine spongiform encephalopathy, which afflicts cows and other animals.

Thermo Fisher Scientific has acquired Prionics, a privately held animal health diagnostics firm. The 17-year-old Swiss company, a spin-off of the University of Zurich, has an R&D lab in Zurich and a production facility in Lelystad, the Netherlands. In 2005, it acquired Pfizer Animal Health’s diagnostics portfolio and now sells more than 50 diagnostic test kits, accessories, and biochemicals. Thermo Fisher has made Prionics part of its Life Technologies business, which it acquired in early February for $13.6 billion.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.